Brief: Piramal Pharma Approves Sale Of Unit For 85 Million Rupees
22/07/2025 07:41
July 22 (Reuters) - Piramal Pharma Ltd PIRM.NS: BOARD APPROVES SALE OF UNIT FOR 85 MILLION RUPEES UNIT DECOMMISSIONED, CONTRIBUTED NIL TO TURNOVER Source text: ID:nBSE4nC3jR Further company coverage: PIRM.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington